Brain metastases from hepatocellular carcinoma: Prognostic factors and outcome

Hye Jin Choi, Byung Chul Cho, Joo Hyuk Sohn, Sang Jun Shin, Se Hyun Kim, Joo Hang Kim, Nae Choon Yoo

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in patients with brain metastases from hepatocellular carcinoma. Between 1995 and 2006, 6,919 patients with hepatocellular carcinoma were treated at Yonsei University Health System. Of those, 62 (0.9%) had a diagnosis of brain metastasis. We carried out a retrospective review of these 62 patients and performed a statistical analysis. The median age at the time patients were diagnosed with brain metastasis was 54 years. Forty-seven patients (76%) were male, and 53 patients had hepatitis B. Median time from diagnosis of hepatocellular carcinoma to brain metastasis was 18.2 months, and 5 patients had brain involvement as their initial presentation. Intracranial hemorrhage was frequently associated (54.8%) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Metastases were treated with whole-brain radiation therapy (WBRT) alone in 17 patients and gamma knife surgery alone in 10 patients. Six patients underwent surgical resection and 5 patients were treated with surgical resection followed by WBRT. Twenty-four patients (39%) received steroids only. Median survival after diagnosis of brain metastasis was 6.8 weeks (95% confidence interval: 3.8-9.8 weeks). Univariate analysis showed that treatment modality, number of brain lesions, α-fetoprotein, ECOG performance score, recursive partitioning analysis (RPA) class, and Child-Pugh classification had a statistically significant impact on survival. In multivariate analysis, treatment modality, number of brain lesions, and Child-Pugh classification were statistically significant prognostic factors for survival. The overall prognosis of patients with brain metastases from hepatocellular carcinoma is extremely poor. Nevertheless, some subsets of patients manifested the most favorable survival criteria (single brain metastasis and good liver function); thus, for at least these patients, treatment may result in an improved survival time.

Original languageEnglish
Pages (from-to)307-313
Number of pages7
JournalJournal of Neuro-Oncology
Volume91
Issue number3
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Hepatocellular Carcinoma
Neoplasm Metastasis
Brain
Survival
Radiotherapy
Fetal Proteins
Intracranial Hemorrhages
Natural History
Hepatitis B
Headache
Therapeutics
Multivariate Analysis
Steroids
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Choi, H. J., Cho, B. C., Sohn, J. H., Shin, S. J., Kim, S. H., Kim, J. H., & Yoo, N. C. (2009). Brain metastases from hepatocellular carcinoma: Prognostic factors and outcome. Journal of Neuro-Oncology, 91(3), 307-313. https://doi.org/10.1007/s11060-008-9713-3
Choi, Hye Jin ; Cho, Byung Chul ; Sohn, Joo Hyuk ; Shin, Sang Jun ; Kim, Se Hyun ; Kim, Joo Hang ; Yoo, Nae Choon. / Brain metastases from hepatocellular carcinoma : Prognostic factors and outcome. In: Journal of Neuro-Oncology. 2009 ; Vol. 91, No. 3. pp. 307-313.
@article{eb3dcc9404754d619ebb2517932b8296,
title = "Brain metastases from hepatocellular carcinoma: Prognostic factors and outcome",
abstract = "Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in patients with brain metastases from hepatocellular carcinoma. Between 1995 and 2006, 6,919 patients with hepatocellular carcinoma were treated at Yonsei University Health System. Of those, 62 (0.9{\%}) had a diagnosis of brain metastasis. We carried out a retrospective review of these 62 patients and performed a statistical analysis. The median age at the time patients were diagnosed with brain metastasis was 54 years. Forty-seven patients (76{\%}) were male, and 53 patients had hepatitis B. Median time from diagnosis of hepatocellular carcinoma to brain metastasis was 18.2 months, and 5 patients had brain involvement as their initial presentation. Intracranial hemorrhage was frequently associated (54.8{\%}) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Metastases were treated with whole-brain radiation therapy (WBRT) alone in 17 patients and gamma knife surgery alone in 10 patients. Six patients underwent surgical resection and 5 patients were treated with surgical resection followed by WBRT. Twenty-four patients (39{\%}) received steroids only. Median survival after diagnosis of brain metastasis was 6.8 weeks (95{\%} confidence interval: 3.8-9.8 weeks). Univariate analysis showed that treatment modality, number of brain lesions, α-fetoprotein, ECOG performance score, recursive partitioning analysis (RPA) class, and Child-Pugh classification had a statistically significant impact on survival. In multivariate analysis, treatment modality, number of brain lesions, and Child-Pugh classification were statistically significant prognostic factors for survival. The overall prognosis of patients with brain metastases from hepatocellular carcinoma is extremely poor. Nevertheless, some subsets of patients manifested the most favorable survival criteria (single brain metastasis and good liver function); thus, for at least these patients, treatment may result in an improved survival time.",
author = "Choi, {Hye Jin} and Cho, {Byung Chul} and Sohn, {Joo Hyuk} and Shin, {Sang Jun} and Kim, {Se Hyun} and Kim, {Joo Hang} and Yoo, {Nae Choon}",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s11060-008-9713-3",
language = "English",
volume = "91",
pages = "307--313",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

Brain metastases from hepatocellular carcinoma : Prognostic factors and outcome. / Choi, Hye Jin; Cho, Byung Chul; Sohn, Joo Hyuk; Shin, Sang Jun; Kim, Se Hyun; Kim, Joo Hang; Yoo, Nae Choon.

In: Journal of Neuro-Oncology, Vol. 91, No. 3, 01.01.2009, p. 307-313.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Brain metastases from hepatocellular carcinoma

T2 - Prognostic factors and outcome

AU - Choi, Hye Jin

AU - Cho, Byung Chul

AU - Sohn, Joo Hyuk

AU - Shin, Sang Jun

AU - Kim, Se Hyun

AU - Kim, Joo Hang

AU - Yoo, Nae Choon

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in patients with brain metastases from hepatocellular carcinoma. Between 1995 and 2006, 6,919 patients with hepatocellular carcinoma were treated at Yonsei University Health System. Of those, 62 (0.9%) had a diagnosis of brain metastasis. We carried out a retrospective review of these 62 patients and performed a statistical analysis. The median age at the time patients were diagnosed with brain metastasis was 54 years. Forty-seven patients (76%) were male, and 53 patients had hepatitis B. Median time from diagnosis of hepatocellular carcinoma to brain metastasis was 18.2 months, and 5 patients had brain involvement as their initial presentation. Intracranial hemorrhage was frequently associated (54.8%) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Metastases were treated with whole-brain radiation therapy (WBRT) alone in 17 patients and gamma knife surgery alone in 10 patients. Six patients underwent surgical resection and 5 patients were treated with surgical resection followed by WBRT. Twenty-four patients (39%) received steroids only. Median survival after diagnosis of brain metastasis was 6.8 weeks (95% confidence interval: 3.8-9.8 weeks). Univariate analysis showed that treatment modality, number of brain lesions, α-fetoprotein, ECOG performance score, recursive partitioning analysis (RPA) class, and Child-Pugh classification had a statistically significant impact on survival. In multivariate analysis, treatment modality, number of brain lesions, and Child-Pugh classification were statistically significant prognostic factors for survival. The overall prognosis of patients with brain metastases from hepatocellular carcinoma is extremely poor. Nevertheless, some subsets of patients manifested the most favorable survival criteria (single brain metastasis and good liver function); thus, for at least these patients, treatment may result in an improved survival time.

AB - Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in patients with brain metastases from hepatocellular carcinoma. Between 1995 and 2006, 6,919 patients with hepatocellular carcinoma were treated at Yonsei University Health System. Of those, 62 (0.9%) had a diagnosis of brain metastasis. We carried out a retrospective review of these 62 patients and performed a statistical analysis. The median age at the time patients were diagnosed with brain metastasis was 54 years. Forty-seven patients (76%) were male, and 53 patients had hepatitis B. Median time from diagnosis of hepatocellular carcinoma to brain metastasis was 18.2 months, and 5 patients had brain involvement as their initial presentation. Intracranial hemorrhage was frequently associated (54.8%) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Metastases were treated with whole-brain radiation therapy (WBRT) alone in 17 patients and gamma knife surgery alone in 10 patients. Six patients underwent surgical resection and 5 patients were treated with surgical resection followed by WBRT. Twenty-four patients (39%) received steroids only. Median survival after diagnosis of brain metastasis was 6.8 weeks (95% confidence interval: 3.8-9.8 weeks). Univariate analysis showed that treatment modality, number of brain lesions, α-fetoprotein, ECOG performance score, recursive partitioning analysis (RPA) class, and Child-Pugh classification had a statistically significant impact on survival. In multivariate analysis, treatment modality, number of brain lesions, and Child-Pugh classification were statistically significant prognostic factors for survival. The overall prognosis of patients with brain metastases from hepatocellular carcinoma is extremely poor. Nevertheless, some subsets of patients manifested the most favorable survival criteria (single brain metastasis and good liver function); thus, for at least these patients, treatment may result in an improved survival time.

UR - http://www.scopus.com/inward/record.url?scp=58149464149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149464149&partnerID=8YFLogxK

U2 - 10.1007/s11060-008-9713-3

DO - 10.1007/s11060-008-9713-3

M3 - Article

C2 - 18949445

AN - SCOPUS:58149464149

VL - 91

SP - 307

EP - 313

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -